Cardiovascular health and life expectancy free of atherosclerotic cardiovascular disease among patients with type 2 diabetes: a cohort study
Higher levels of CVH in individuals with diabetes extend their life expectancy free from ASCVD, bringing it closer to that of individuals without diabetes. We have provided an important addition to the current evidence advocating for CVH-enhancing strategies in diabetic patients.
Authors
- Yuxin He (ORCID: https://orcid.org/0000-0001-9110-9244)
- Xianbao Liu (ORCID: https://orcid.org/0000-0003-1556-9198)
- Yanxia Wei (ORCID: https://orcid.org/0000-0001-9245-2722)
- Stella Ng
- Jianan Wang (ORCID: https://orcid.org/0000-0002-4583-3204)
- Deqiang Sun
Institutions
- Netherlands Heart Registration (NL)
- Molecular Devices (United Kingdom) (GB)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1093/eurjpc/zwaf742
- Citations
- 1
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 1.29